Study Stopped
No enough participants recruited
Arthroscopic Partial Meniscectomy Time Window
Effect of Early vs Delayed Arthroscopic Partial Meniscectomy on the Knee Function of Patients With Degenerative Meniscus Lesions
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The purpose was to assess knee function outcomes between early arthroscopic partial meniscectomy(APM) and delayed APM for patients with degenerative meniscus lesions(DMLs)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2020
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 12, 2020
CompletedFirst Submitted
Initial submission to the registry
December 7, 2022
CompletedFirst Posted
Study publicly available on registry
December 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2023
CompletedMarch 14, 2023
March 1, 2023
3.5 years
December 7, 2022
March 10, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
the Knee Injury and Osteoarthritis Outcome Score (KOOS) change
The Knee injury and Osteoarthritis Outcome Score (KOOS) holds five subscales including: Pain (9 items); other Symptoms (7 items); Activities of Daily Living (ADL, 17 items); Sport and Recreation function (Sport/Rec, 5 items); and knee-related Quality of Life (QoL, 4 items). Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems)
change from baseline up to 12 months
International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC Score) change
The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC) score questionnaire contains 18 items (7 items for symptoms, 1 item for sport activity, 9 items for daily activities, and 1 item for current knee function.) The total score is transformed to a value on a scale of 0 to 100, with 100 representing the highest knee function and 0 is the worst.
change from baseline up to 12 months
Kellgren-Lawrence (K/L) grade change
Kellgren-Lawrence (K/L) grade via X ray
change from baseline up to 12 months
the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) change
Te WOMAC is a self assessed health status scale for patients consisting of 24 items in three subscales of pain (5 items), stiffness (2 items), and physical function (17 items). All items are scored from 0 (asymptomatic) to 4 (very severe), and the total score ranges from 0 to 96, with higher scores indicating more severe symptoms
change from baseline up to 12 months
Secondary Outcomes (5)
KOOS pain score change
change from baseline up to 12 months
KOOS symptoms score change
change from baseline up to 12 months
KOOS activities of daily living score change
change from baseline up to 12 months
KOOS function in sport and recreation score change
change from baseline up to 12 months
KOOS knee related quality of life score change
change from baseline up to 12 months
Study Arms (2)
early APM
EXPERIMENTALearly APM within 3 and 6 month knee pain symptoms
delayed APM
ACTIVE COMPARATORdelayed APM within 6 and 12 month knee pain symptoms
Interventions
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of degenerative meniscus lesions based on knee MRI
You may not qualify if:
- Must be able to have no acute knee injury such as car crash or acute sports injury;
- Must be able to have no knee surgeries history;
- Must be able to have no rheumatoid arthritis or serious knee osteoarthritis with deformity;
- Must be able to have no contraindications to MRI;
- Must be able to have no severe cardiopulmonary disease;
- Must be able to have no musculoskeletal or neuromuscular impairments ;
- Must be able to have good visual, hearing, or cognitive;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Hongyu Wang, Doctor
Shenzhen People's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 7, 2022
First Posted
December 19, 2022
Study Start
January 12, 2020
Primary Completion
July 5, 2023
Study Completion
August 28, 2023
Last Updated
March 14, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share